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In view of the developments in health care relating to the increased prevalence and incidence of
chronic diseases and the continuing increase in health-care expenditure, more attention should
be paid to health maintenance and disease prevention. Any strategy that can influence health
maintenance is of interest, especially lifestyle factors such as nutrition, exercise or stress
control. Alcohol has an important place in the daily life of many healthy as well as sick
individuals. Alcohol has three major characteristics; it is a nutrient (energy source), a psycho-
active drug and a toxin. Each consumer has the choice of which of the characteristics of alcohol
he/she wants to utilise. Thus, alcohol represents one of the most important self-implemented
disease modifiers in our modern society. The major determinants of the health effects of
alcohol are the absolute amount consumed, the consumption frequency, associated lifestyle
factors (e.g. smoking, nutrient intake, substrate composition, physical activity pattern) and last,
but not least, the genetic background. There are few known disease conditions that have not
already been associated positively or negatively with alcohol consumption. The list of diseases
includes atherosclerosis, dementia, diabetes, obesity and conditions relating to Zn metabolism.
Obesity represents the most important disease modifier in the world and the prevalence rates
are increasing rapidly. Evidence suggests that alcohol represents a risk factor for overweight
and obesity as a result of specific effects on energy metabolism and substrate metabolism. The
potential role of alcohol as an important modulator for the postprandial lipidaemia and its role
in the pathogenesis of modern diseases will be discussed.
Alcohol: Health maintenance: Disease prevention
The importance of alcohol as a disease modifier is well
established. Despite the well-known negative as well as
positive aspects of its role in the pathogenesis of different
chronic diseases such as coronary artery disease (CAD) or
cancer (Leppala et al. 1999; MacDonald, 1999; Ruf, 1999;
Suter, 2001a; Mukamal et al. 2003), the controversy about
the ‘ideal’ intake of alcohol for health maintenance
continues.
In view of the recent developments in the health-care
system, with a continuing increase in health-care costs,
disease prevention is gaining more attention. Any success-
ful strategy for disease prevention is of interest, as long as
the side effects remain in an acceptable range, which for
alcohol is not always the case. However, if consumers can
avoid excessive intake, alcohol can be beneficial. Com-
pared with other disease risk factors that have a strong
foundation of evidence relating to their pathogenesis as
well as treatment, the role of alcohol as a preventive agent
is less well established and more controversial. The role of
alcohol as a preventive agent for CVD is accepted by most
patients and by many physicians, which is, in view of the
high potential for negative effects, rather astonishing. The
reason for the acceptance of a substance with considerable
side effects is related to the different characteristics of
alcohol (psycho-active drug) as well as the fact that it is
much easier and less demanding to have a drink than to
walk or jog 1 km or to reduce energy intake. Accordingly,
in a recent survey of patterns of health behaviour in US
adults the adherence status for different health recommen-
dations was comparatively good for the recommendation
to consume daily one drink or less for women and two
drinks or less for men (Berrigan et al. 2003). Of the
population surveyed >70% adhered to the latter recom-
mendation. However, only 40% reported adherence to the
exercise recommendation and 35% adhered to the recom-
mendation to increase intake of fruit and vegetables.
Despite the controversy about the role of alcohol in
disease prevention, alcohol cannot be disregarded in
modern society and there should be comprehensive guide-
lines for sensible drinking and educational means should
be found to avoid the growth of excessive drinking (Inter-
Departmental Working Group, 1995).
Abbreviation: CAD, coronary artery disease.
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There is no chronic disease that is not affected by
alcohol, and indeed light to moderate alcohol intake may
both positively and negatively modulate the disease burden
in most societies. The healthy life expectancy in the UK is
69.6 years and the expected loss of healthy years at birth is
about 9 years for men and women (i.e. about 8–11% of the
total life expectancy is lost: World Health Organization,
2001). At higher intakes alcohol can have an effect on all
the top ten causes of burden of disease (World Health
Organization, 2002). However, small intakes of alcohol
may have favourable effects on CVD, which still
represents the top cause of burden of disease.
In the present short review selected aspects of the role of
alcohol in health maintenance and disease prevention are
discussed. Special attention is given to its role in CAD,
hypertension and as a modulator of postprandial metabolism.
Alcohol: an important health modulator
Alcohol is positively and/or negatively associated with the
major determinants of health. Excessive alcohol intake is
negatively associated with most socio-economic determi-
nants of health (e.g. poverty, lower educational status,
selected psychological factors, unemployment, etc). In
addition, alcohol is associated with most modifiable
lifestyle risk factors (physical inactivity, smoking, mal-
nutrition, stress, etc). Thus, alcohol consumption in combin-
ation with these risk factors leads to a disproportional
increase in risk (Gallus et al. 2003; Salaspuro, 2003).
According to the WHO European Health Report (World
Health Organization, 2002) 55 000 young Europeans die
each year from the effects of alcohol abuse and one in four
deaths in European men aged 15–29 years is related to
alcohol. Furthermore, 40–60% of all deaths from injuries
are attributable to alcohol. The total cost to society caused
by the uncontrolled intake of alcohol corresponds to 1–3%
of the gross domestic product (World Health Organization,
2002). The major alcohol-related diseases are liver
cirrhosis, hypertension, alcoholic heart disease, stroke,
pancreatitis and different cancers (oro-pharynx, larynx,
oesophagus, stomach, liver and rectum). In view of the
many negative effects of alcohol, the cardio-protective
effects seem to be overrated; however, it should be
remembered that >20% of the burden of disease is caused
by CVD. Thus, the potential positive effects of alcohol
could become relevant in a society in which alcohol
consumption is not excessive. In a recent systematic
review even a warning for ‘insufficient’ alcohol intake
has been formulated (White et al. 2002).
Alcohol and coronary artery disease
CAD represents the principal burden of disease, and any
means available to reduce the morbidity and mortality of
CAD would be welcomed. Alcohol has been consistently
associated with a reduced risk of CAD (Agarwal, 2002).
Most prospective and retrospective studies have reported
an alcohol-induced reduction in cardiovascular risk
(Boffetta & Garfinkel, 1990; Wannamethee & Sharper,
1998; Leppala et al. 1999; White et al. 2002). During the
last 20 years the level of alcohol that has been shown to be
associated with a reduced cardiovascular risk has declined
from moderate amounts (20–30 g/d) to small amounts
(5–15 g/d). It seems that even very small amounts of
alcohol can reduce the risk of CVD (Klatsky et al. 1986a);
the rate of hospital admission as a result of myocardial
infarction was significantly (P < 0.03) reduced in individ-
uals who consumed alcohol less than once per week
but more than once per month. So far, no single major
mechanism for the cardio-protective effect of alcohol
has been identified. Different putative mechanisms,
such as effects on the plasma lipid profile, thrombogenesis
or hormones, have been identified (Agarwal, 2002).
The protective effects of alcohol are more pronounced
in consumers of advanced age and in individuals
with established cardiovascular risk factors (Boffetta
& Garfinkel, 1990), which suggests that alcohol may
favourably modulate existing cardiovascular risk factors.
The evidence for this role is that alcohol may aggravate
certain cardiovascular risk factors, such as blood pressure
or plasma lipoprotein concentrations (see pp. 84–85), but
nevertheless elicits protection. This apparent conflict
represents one of the central ‘paradoxes’ surrounding the
health effects of alcohol.
The alcohol-related reduction in CAD risk despite an
unhealthy diet rich in saturated fat corresponds to the
‘French Paradox’ (Renaud & de Lorgeril, 1992; Renaud &
Gueguen, 1998), and also provides further support for the
role of alcohol as a risk factor modulator (Boffetta &
Garfinkel, 1990). The effect of alcohol as a cardiovascular
risk factor modulator implies that under an optimal control
of the conventional risk factors, alcohol would add only a
small additional amount of cardio-protection. Unfortu-
nately, there are few data relating to this issue; never-
theless, the hypothesis is supported by the data set of the
American Cancer Society Study, which showed that the
cardio-protective effects of alcohol were considerably
smaller in subjects without existing cardiovascular risk
factors (Boffetta & Garfinkel, 1990). Furthermore, a recent
systematic review has concluded that the lowest level of
alcohol intake for optimal cardiovascular prevention will
decline in future years as a result of better risk factor
control (White et al. 2002).
Another paradox associated with the effects of alcohol
on CVD risk concerns the effect of alcohol on plasma
homocysteine concentration. Alcohol leads to an increase
in plasma homocysteine levels, which is regarded as an
independent cardiovascular risk factor (i.e. the ‘homocys-
teine paradox of alcohol’; Refsum et al. 1998; Mangoni &
Jackson, 2002). Most of the classical risk factors of
atherosclerosis (age, hypertension, obesity and lifestyle
factors such as physical activity, smoking, high coffee
consumption and alcohol) influence plasma homocysteine
levels (Nygard et al. 1998). The increase in plasma
homocysteine may even counterbalance the protective
effect of moderate alcohol consumption (Bleich et al.
2001; Halstred, 2001). The cardio-protective effect despite
elevated homocysteine levels could be the result of
modulation of the effects of homocysteine by alcohol.
The negative effect of alcohol on homocysteine can be
overcome by increasing the intake of fruit and vegetables,
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i.e. the major source of folate, which is the most important
factor in the reduction of plasma homocysteine concentra-
tion (Suter, 2001b). In alcohol consumers increased fruit
and vegetable intake can lead to a reduction in the plasma
homocysteine levels, even in individuals with a genetic
polymorphism that gives rise to elevated plasma homo-
cysteine levels (Folsom et al. 1998). This observation is
important because it indicates that a genetic disadvantage
can be overcome by improved nutrition. Fruit and
vegetables represent the most important nutritional disease
modifier (Ziegler, 1991; Ness & Powles, 1997; Joshipura
et al. 1999, 2001; Suter, 2001b). Unfortunately, in most
populations fruit and vegetable intake is rather low and
there is an inverse relationship between the consumption of
fruits and vegetables and alcohol intake (Johnsen et al.
2003). Furthermore, it is easier to follow the recommend-
ation ‘to drink moderately but not too much’ than to follow
the recommendation ‘to increase fruit and vegetable
consumption’ (Berrigan et al. 2003).
Another ‘alcohol paradox’ is the effect of alcohol on
insulin resistance, i.e. acute alcohol dosage leads to a
decrease in insulin sensitivity. However, several cross-
sectional studies have shown that chronic moderate alcohol
intake is associated with improved insulin sensitivity
(decreased insulin resistance; Zilkens & Puddey, 2003).
Several prospective studies have shown a decreased risk of
diabetes in regular light to moderate alcohol consumers
(Wannamethee et al. 2003; Zilkens & Puddey, 2003). A
recent study found a linear inverse relationship between
alcohol intake and the risk of type 2 diabetes with £30 g
alcohol, but above this level the risk increased compared
with light and moderate intake (Wannamethee et al. 2003).
The same study reported a protective effect on type 2
diabetes that was independent of the frequency of
consumption, but found slightly stronger protection with
increasing frequency (i.e. 4–7 d/week v. one to three times
per week) when the same amount of alcohol was
consumed (5.0–29.9 g/d). A recent study of the relationship
between alcohol intake and CAD confirmed the previous
observation that non-daily alcohol intake is also associated
with a reduced cardiovascular risk (Mukamal et al. 2003).
In this study alcohol intake on ‡3 d/week was associated
with a reduced risk of CAD. There is growing evidence
that the consumption of more than one drink every 2 d
offers little incremental increase in benefit for cardiovas-
cular risk (Maclure, 1993; Mukamal et al. 2003).
Very small amounts of alcohol (‡5 g/d) appear to be
effective in chronic disease prevention, as is non-daily
consumption. Daily consumption is highly correlated with
the absolute amount of alcohol consumed, and also carries
a higher risk of dependency. However, the question of
whether the protective effect is related to the drink or the
drinker has been the subject of a recent editorial (Klatsky,
1999). It is likely that the characteristics of the drinker
are usually underestimated in the discussion of the
protective effect of alcohol on chronic disease risk. The
level of alcohol intake as well as the type of alcoholic
beverage is associated with a variety of characteristics
(socio-demographic, lifestyle such as diet, physical activity
pattern, smoking) that all have a high potential to modulate
alcohol effects (Mortensen et al. 2001; Burger et al. 2003).
Thus, in the range of light to moderate alcohol intake the
characteristics of the drinker (including genetics) might be
as important as the effects of alcohol (Klatsky et al. 1990;
Hines et al. 2001).
Hypertension
Excessive alcohol consumption has been identified as one
of the most important factors leading to increased blood
pressure and frank hypertension (Suter & Vetter, 2000).
Although the pathogenesis of hypertension is multifactori-
al, alcohol does play an important role in the pathogenesis
of essential hypertension. Most studies examining the
relationship between alcohol and blood pressure have
found a curvilinear (i.e. ‘J’- or ‘U’-shaped) relationship. In
several studies a threshold effect has been described. In the
classical study from the Kaiser-Permanente group, Klatsky
and coworkers (Klatsky et al. 1977; Klatsky & Friedman,
1984) found a progressive relationship between alcohol
intake and blood pressure that was independent of gender,
age, body weight, socio-economic status, smoking habits
or ethnic background. In several studies no significant
relationship was found in non-daily drinkers, whereas in
daily consumers blood pressure increased linearly across
all consumption categories (Donahue et al. 1986; Potter &
Beevers, 1991; Russell et al. 1991; Suter et al. 1995).
Although there is a strong relationship between the
frequency of drinking and the amount of alcohol consumed
(Bulpitt et al. 1987), the pathophysiological potential of a
fixed amount of alcohol may vary according to the
frequency of consumption. The effect of the consumption
frequency on blood pressure is controversial. In the Kaiser-
Permanente Study the amount of alcohol ingested and the
level of blood pressure were only weakly related (Klatsky
et al. 1986b), and other investigators have described
similar findings (Russell et al. 1991; Ueshima et al.
1992). In most studies less-frequent alcohol intake is
usually associated with lower alcohol intake and lower
blood pressure (Russell et al. 1991). Using a hierarchical
regression analysis it was observed that a more frequent
intake of alcohol was associated with higher blood
pressure independent of the amount of alcohol consumed
(Russell et al. 1991). Thus, an individual consuming
alcohol on a daily basis would have a systolic blood
pressure that is 6.6 mmHg higher than that of an individual
consuming the same amount of alcohol on a weekly basis.
These findings provide further support for a non-daily
alcohol intake.
In the present context it should be mentioned that
occasional alcohol intake could also have favourable
effects on Na balance and thus blood pressure. The effects
of alcohol on suppression of the secretion of vasopressin
(antidiuretic hormone) have been known for many years
(Kleemen et al. 1955; Leppaluoto et al. 1992). In a recent
study (P Suter and A Schibli, unpublished results) Na and
NaCl excretion after a parenteral 5 g NaCl load with and
without alcohol (0.5 g/kg body weight) were measured
during a 7 h period. The ingestion of alcohol led to
increased excretion of water and NaCl during the first few
hours, for as long as the alcohol remained in the circulation
(over the 7 h period the difference in NaCl excretion was
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>1 g; P < 0.05). The experiment was carried out under an
optimal hydration state. This finding suggests that when a
meal rich in NaCl is ingested a high level of (non-
alcoholic) fluid intake (Choukroun et al. 1997) and a
moderate amount of alcohol could promote the elimination
of the Na load. In view of the potential importance of NaCl
in hypertension (He & MacGregor, 2002) even a modest
improvement in the Na balance may be of clinical
importance. Nevertheless, in the clinical setting of
hypertension and Na sensitivity the control of NaCl intake
as well as avoidance of excessive alcohol consumption
should have priority.
Alcohol and postprandial metabolism
It was >20 years ago that Zilversmit (1979, 1995)
postulated that atherosclerosis may represent a postpran-
dial phenomenon. This hypothesis has gained considerable
support during the last few years. It has been shown that
during the postprandial phase there are many proathero-
genic events and, often, cardiovascular events (Silveira,
2001; Servoss et al. 2002). The large changes in lipid
concentration that persist during the postprandial phase
may enhance the development of atherosclerosis. A typical
feature of alcohol consumption is fasting, as well as
postprandial, hypertriacylglycerolaemia (Taskinen &
Nikkila¨, 1977; Taskinen et al. 1987; Pownall et al. 1999).
The lipid changes during the postprandial phase, such as
the increased concentration of chylomicrons and triacyl-
glycerols, may have a causal role in the development and
progression of atherosclerosis (Austin, 1999; Ginsberg,
2002; Segrest, 2002). Alcohol has cardio-protective
effects, despite its negative effect on postprandial lipidae-
mia, which can be considered to be another paradox.
Considering these findings it is possible that alcohol may
affect the characteristics of lipid particles in the post-
prandial phase (e.g. modulate particle size and/or composi-
tion) so that they become less atherogenic. In general, any
factor that reduces postprandial lipidaemia may be
considered to be cardio-protective (Parks, 2001; Petitt &
Cureton, 2003).
Exercise represents one of the central strategies for
disease prevention (Thompson et al. 2003). Thus, a study
of the postprandial lipid response to an oral fat load with
and without alcohol was carried out recently in trained
healthy young men after an exercise session and in
untrained healthy men who did not undertake the exercise
session (Suter et al. 2001). All subjects were of normal
weight (BMI (kg/m2): trained subjects 21.6 (SE 1.5),
untrained 23.2 (SE 1.8)) and received 1 g fat/kg body
weight with and without alcohol (0.5 g/kg body weight).
The trained subjects performed a jogging session of 5.4 km
(running speed 10–13 km/h) before ingestion of the meal.
In the trained subjects the ingestion of alcohol led to an
increase in the triacylglycerol area under the curve from
7.4 (SE 0.04) mmol/l.h on the control day to 11.3
(SE 0.9) mmol/l.h on the experimental day (P = 0.001; Suter
et al. 2001). The corresponding areas under the curve in
the untrained subjects were 13.4 (SE 2.3) mmol/l.h and 19.4
(SE 3.5) mmol/l.h (P = 0.004). Alcohol intake and level of
physical activity training as well as the pre-meal exercise
session were the major determinants of the postprandial
lipidaemia. The ingestion of a fat meal in combination
with alcohol led to an increase in postprandial lipidaemia
that was independent of the level of training. Nevertheless,
a higher level of training was associated with a lower
postprandial triacylglycerol response (lower peak concen-
tration and shorter postprandial lipidaemia). Since alcohol
has cardio-protective effects, the alcohol-induced increase
in postprandial lipidaemia appears to have a lower
pathogenetic potential than the non-alcohol-related
increase in postprandial lipidaemia. The data suggest that
the (potentially) unfavourable effect of alcohol and a high-
fat diet could be modified by fat restriction or a com-
bination of a pre-meal exercise session and a higher level
of physical activity (Suter et al. 1993, 1994, 2001).
HDL-cholesterol concentrations, as well as those of
other lipid fractions, vary during the day as a function of
food intake (Miida et al. 2002). In agreement with other
studies, during the postprandial phase a decline in the
HDL-cholesterol level was observed in alcohol intake
studies and there was a return to the initial pre-meal value
within approximately 8 h (Suter et al. 2001). It is possible
that the lower HDL-cholesterol levels in individuals with a
high meal frequency could be a result of the longer
duration of increased triacylglycerol levels (Lamarche et al.
1999). In view of the central role of HDL-cholesterol in
atherogenesis (Tulenko & Sumner, 2002) any strategy that
avoids, or at least reduces, the postprandial decline in
HDL-cholesterol may be beneficial in controlling the
risk of atherosclerosis in the long term. As the HDL-
cholesterol-raising effect of alcohol is well known (Fraser
et al. 1983), it is possible that the postprandial reduction in
the plasma HDL concentration could be counterbalanced
by the ingestion of alcohol with a meal and/or as an
aperitif. The ‘Aperitif Study’ investigated postprandial
metabolism in fourteen young men (aged 27.2 (SE 1.2)
years, BMI 23.7 (SE 0.6) kg/m2) after ingestion of a meal
(1 g fat/kg body weight) with or without alcohol (0.5 g/kg
body weight) with the meal and with (0.2 g alcohol/kg
body weight) or without (water) an alcoholic aperitif
90 min before the test meal. The amount of alcohol given
as an aperitif was 15.3 (SE 0.4) g and the amount given
with the meal was 38.2 (SE 0.9) g. Each subject received
each of the following combinations: alcoholic aperitif +
water with the meal; alcoholic aperitif + alcohol with the
meal; water before the meal + alcohol with the meal.
During the 90 min aperitif phase of the study a blood
sample was taken every 30 min. At 90 min after the meal a
blood sample was taken every 60 min and analysed for
glucose, insulin, triacylglycerols, total cholesterol, HDL-
cholesterol, blood alcohol concentration and other vari-
ables. The peak triacylglycerol concentration, as well as
the triacylglycerol area under the curve (for the whole 8 h
period), was highest after the alcoholic aperitif + alcohol
with the meal intervention (P < 0.05).
The suppression of NEFA by alcohol or ingestion of
food is well known (Suter et al. 1992). During the last few
years evidence has accumulated that NEFA and/or signals
induced by NEFA have a key role in the induction as
well as the progression of atherosclerosis, and also in
the development of chronic diseases including insulin
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resistance (Zilversmit, 1995; Castro-Cabezas et al. 2001;
Boord et al. 2002; Yli-Jama et al. 2002; Esenabhalu et al.
2003). Endothelial dysfunction probably represents one of
the early steps in atherogenesis, and it seems that NEFA
overload contributes to vascular dysfunction (Esenabhalu
et al. 2003). Increased NEFA and lipotoxicity may
represent a central phenomenon in the development of
the metabolic syndrome (Listenberger et al. 2003; Unger,
2003). Thus, any strategy that has a favourable affect on
NEFA metabolism (e.g. NEFA plasma concentration)
would represent protection from these diseases. Data from
the Italian National Research Council Study suggests that
alcohol consumed with a meal could be more cardio-
protective than alcohol consumed alone (Trevisan et al.
1987). This effect could be a result of the potential effects
of alcohol on lipid particle concentration as well as the
effects of the lower concentration of NEFA. Furthermore,
the ingestion of alcohol together with a meal leads to lower
peak blood alcohol concentrations. In the aperitif study the
postprandial suppression of the NEFA concentration was
greater after the alcoholic aperitif + alcohol with the meal
and the water before the meal + alcohol with the meal
interventions than after the alcoholic aperitif + water with
the meal intervention. The suppression of the NEFA after
the water before the meal + alcohol with the meal and the
alcoholic aperitif + alcohol with the meal interventions was
identical. The area under the curve for the NEFA was
significantly higher with the alcoholic aperitif + water with
the meal than with the other interventions (P < 0.05).
Elevated fatty acids impair the effect of insulin on glucose
uptake in skeletal muscle and induce endothelial dysfunc-
tion, and thus enhance atherogenesis (Steinberg & Baron,
2002). Inflammation and inflammatory mediators are major
participants in atherogenesis as well as in the pathogenesis
of the insulin resistance syndrome, and complement factors
are involved in cellular NEFA uptake (Meijssen et al.
2002). During the postprandial phase elevated NEFA may
even have a higher pathophysiological potential.
Alcohol consumption may lead to an increase in fasting
HDL-cholesterol levels but alcohol does not appear to
counterbalance the postprandial fall in HDL-cholesterol.
Even a preload of alcohol in the form of an aperitif did not
counterbalance the HDL-cholesterol-lowering effect of the
meal. Also, when investigated with the combination of
alcohol and pre-meal exercise HDL-cholesterol declined
independently of alcohol intake and/or exercise training
(Suter et al. 2001). This outcome may be a result of an
altered lipid exchange during the postprandial phase
associated with the alcohol-induced increase in the
triacylglycerols (Gotto, 2002). Regular exercise represents
the other central strategy for increasing fasting HDL-
cholesterol (Durstine et al. 2002). Recently, the effect of a
preprandial walking session on lipidaemia 4 h after a meal
was investigated (P Suter and S Pollakis, unpublished
results). A preprandial walking session of 1 h duration
(distance 6.6 km) led to a significant reduction in the
postprandial decline in the HDL-cholesterol level 4 h after
the ingestion of a standard meal (1 g fat/kg body weight)
without alcohol. In this study no alcohol was ingested.
Plasma HDL-cholesterol concentration declined by 0.07
(SE 0.01) mmol/l on the control day and by 0.01
(SE 0.01) mmol/l on the intervention day (P = 0.04). In
addition, the postprandial increase in the insulin concen-
tration at 4 h was 38% lower on the intervention day as
compared with the control day. In this small group of
ten randomly-selected healthy elderly subjects (aged ‡65
years) the plasma triacylglycerol concentration surprisingly
was not affected by the walking intervention (this finding
may be because of two prediabetic subjects who had an
exaggerated postprandial lipid response). It can be argued
that, considering the alcohol-induced increase in fasting
HDL-cholesterol, the observed postprandial reduction in
HDL-cholesterol is of only minor pathophysiological
importance. Currently, the pathophysiological importance
of the postprandial reduction in HDL-cholesterol is not
known. However, it is possible that because of the large
impact of a small change in HDL-cholesterol on the risk of
CAD and the persistence of the postprandial reduction for
several hours, an increased risk may result from this
reduction in the long term. There is an inverse relationship
between the fasting HDL-cholesterol concentration and the
fasting triacylglycerol concentration and postprandial
lipidaemia (triacylglycerol area under the curve and peak
triacylglycerol concentration; Gotto, 2002). Alcohol sup-
presses NEFA, which may confer considerable toxicity and
may thus have protective effects for certain chronic
diseases (CAD and diabetes). In view of the potential
proatherogenic effects of the postprandial lipid changes, a
preprandial exercise session (especially before a fat-rich
meal) can be recommended. If alcohol is consumed it
should be ingested together with a meal. To minimise the
risk of overweight, energy intake should be according to
energy requirements (Suter et al. 1997).
Conclusion
Light to moderate amounts of alcohol may have cardio-
protective effects through different mechanisms. There is
strong evidence to suggest that alcohol favourably modu-
lates the pathophysiological effects of existing cardio-
vascular risk factors. There is increasing evidence that a
major part of the pathogenesis of atherosclerosis occurs
during the postprandial phase, and epidemiological evi-
dence suggests that alcohol ingested with a meal does elicit
greater protection than alcohol without a meal. Despite
the favourable effect of alcohol on HDL-cholesterol,
alcohol cannot prevent the temporary postprandial fall in
HDL-cholesterol. Nevertheless, it appears that moderate
amounts of alcohol modulate postprandial metabolism
(e.g. suppression of the potentially-toxic NEFA). Thus,
the cardio-protective effects of moderate amounts of
alcohol can be increased by the ingestion of alcohol with
a meal.
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